Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.
Renal Cell Carcinoma Stage IV
OTHER: mHealth Smart Phone Application|BEHAVIORAL: eHEALS digital literacy test|BEHAVIORAL: Weekly Quiz|BEHAVIORAL: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire|BEHAVIORAL: Patient Post Intervention Survey
Acceptability of Smart Phone Application, Patient's acceptability of the smart phone application for education will be captured in the patient post education survey., at 6 months
Efficacy of Smart Phone Application -Quality of Life, Efficacy of the smart phone application on patient quality of life will be assessed by the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C-30) scores., at 6 months|Efficacy of Smart Phone Application - Patient Knowledge, Efficacy of the smart phone application on patient knowledge of their diagnosis and treatment will be assessed by weekly true/false quizzes., Weekly, beginning at baseline to month 6
The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.